Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Humoral response to HSV-1 subunit vaccines--a statistical analysis

J R Simms1, A W Heath, V J Richardson

  • 1Division of Molecular and Genetic Medicine, University of Sheffield Medical School, U.K.

Developments in Biological Standardization
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic reactive angioendotheliomatosis mimicking hypertrophic cardiomyopathy in a domestic shorthair cat.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2024
Same author

Monthly engagement with EIP keyworkers was associated with a five-fold increase in the odds of engagement with psychosocial interventions.

BMC psychiatry·2024
Same author

Barriers and facilitators to the implementation of an early intervention in psychosis service in three demonstration sites in Ireland.

BMC health services research·2023
Same author

The Teeth of the Horse and Their Diseases.

The Journal of comparative medicine and surgery·2022
Same author

The Teeth of the Horse and Their Diseases.

The Journal of comparative medicine and surgery·2022
Same author

The Early History of Veterinary Medicine in the United States.

The Journal of comparative medicine and surgery·2022
Same journal

International challenges and public policy issues.

Developments in biological standardization·2000
Same journal

Regulation of biologicals in China.

Developments in biological standardization·2000
Same journal

ICH activities on biotech topics.

Developments in biological standardization·2000
Same journal

Regulation of biologicals in the European Union.

Developments in biological standardization·2000
Same journal

Standardisation and licensing of combination vaccines based on DTP.

Developments in biological standardization·2000
Same journal

Control of foot-and-mouth disease by vaccination.

Developments in biological standardization·2000
See all related articles

Adjuvants significantly boosted immune responses to a herpes simplex virus type 1 (HSV-1) glycoprotein subunit vaccine. Different adjuvants yielded varying levels of antibody production and protection, highlighting their crucial role in vaccine development.

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Herpes simplex virus (HSV) establishes lifelong latency in sensory ganglia.
  • Reactivation of HSV can lead to recurrent lesions, with no current vaccine to prevent transmission.
  • HSV-1 glycoprotein subunit vaccines require enhancement for effective immunogenicity.

Purpose of the Study:

  • To evaluate various commercial and experimental adjuvants for their ability to enhance an HSV-1 glycoprotein subunit vaccine.
  • To assess adjuvant impact on vaccine-induced toxicity, antibody titers, neutralizing antibody production, and protection against lethal HSV-1 challenge.

Main Methods:

  • Testing of multiple adjuvant preparations with an HSV-1 glycoprotein subunit vaccine.
  • Evaluation parameters included toxicity, total antibody levels, and neutralizing antibody production.

Related Experiment Videos

  • Assessment of protection efficacy through lethal HSV-1 challenge in vaccinated subjects.

    • Main Results:

    • All tested adjuvants increased total and neutralizing immunoglobulin (Ig) titers compared to the subunit vaccine alone.
    • Functional neutralizing antibodies were detected with only some adjuvants.
    • A wide range of protective responses was observed post-challenge, independent of antibody levels.

    Conclusions:

    • Adjuvants are essential for eliciting adequate immune responses with subunit vaccines.
    • The choice of adjuvant significantly influences the magnitude and effectiveness of the induced immune response.
    • Further research is needed to correlate specific adjuvant-induced immune profiles with protective outcomes against HSV-1.